On behalf of CHC’s major subsidiary, Hsing-Yeh Biotechnology Co., Ltd., to announce dividend distribution resolved by Board of Directors.
· Issued by CHC Healthcare Group
Close
Today's Information
Provided by: CHC Healthcare Group
SEQ_NO
2
Date of announcement
2022/05/24
Time of announcement
18:28:58
Subject
On behalf of CHC's major subsidiary, Hsing-Yeh
Biotechnology Co., Ltd., to announce dividend
distribution resolved by Board of Directors.
Date of events
2022/05/24
To which item it meets
paragraph 14
Statement
1.Date of the board of directors resolution:2022/05/24
2.Type and monetary amount of dividend distribution:
Cash dividends: NT$ 27,254,038
3.Any other matters that need to be specified:None